Hepatitis A and B Vaccines With SUD Care, Columbus, GA

Learn how hepatitis A and B vaccine guidance applies to adults with substance use in Columbus, GA, and how medical prevention fits a personal care plan.

Two adults discussing notes across a table in a quiet room.

Hepatitis A and hepatitis B vaccination can be important preventive-health topics for adults receiving substance use disorder care. The recommendations are not identical, and neither question should be reduced to whether someone has injected drugs. Age, vaccination history, other health conditions, and the specific virus all matter.

For adults in Columbus, GA, the practical goal is to connect addiction treatment with appropriate medical prevention without confusing their roles. River City Recovery provides adult outpatient addiction and mental health care. That does not establish that hepatitis vaccines, hepatitis testing, or specialty hepatitis treatment are available onsite.

Why discuss hepatitis vaccines during SUD care?

Preventive medical needs can belong alongside substance use and mental health goals without becoming the same service. An individualized addiction treatment plan can recognize questions about hepatitis prevention and connections with outside medical care. River City Recovery’s outpatient addiction care includes care coordination, but recognizing a vaccination need is different from confirming that a program administers vaccines.

Hepatitis A virus, or HAV, and hepatitis B virus, or HBV, affect the liver but have different transmission patterns. The 2020 ACIP hepatitis A recommendations describe HAV transmission primarily through the fecal-oral route, often through person-to-person contact or contaminated food or water. Hepatitis A does not become a chronic infection. Those facts help explain why prevention discussions cannot focus only on blood exposure or injection equipment.

By contrast, the 2022 ACIP hepatitis B recommendations describe transmission through exposure of broken skin or mucous membranes to infectious blood or body fluids. HBV can cause chronic infection. Sexual exposure and injection-related blood exposure are relevant examples, but a person’s substance use history alone does not establish whether infection or immunity is present.

Vaccination, screening, and treatment answer different questions. Vaccination aims to prevent infection. Screening looks for evidence that helps establish infection or immune status. Treatment addresses an identified medical condition. Receiving addiction treatment does not replace those medical decisions, and discussing vaccination does not mean someone has hepatitis. Hepatitis C testing and treatment are separate medical topics, not substitutes for considering HAV and HBV prevention.

What does hepatitis A guidance say about drug use?

Hepatitis A vaccination is relevant to people who use injection or non-injection drugs. The 2020 ACIP recommendation explicitly includes both groups. Within an individualized treatment plan, this can become a medical-prevention question rather than an assumption about how someone uses substances. An outpatient admissions conversation can clarify program services while vaccination decisions remain with an appropriate medical professional.

The recommendation’s stated population is people using injection or non-injection illegal drugs. It should not be broadened into a claim that every substance-related diagnosis has the same risk profile. At the same time, someone who does not inject drugs should not assume that hepatitis A prevention is irrelevant. The route of drug use is not the only consideration in the recommendation.

The ACIP report describes outbreaks among people who use drugs and explains that fecal-oral transmission can occur where hygiene or sanitation is difficult to maintain. This is a public-health concern, not a judgment about someone’s character. Access to clean facilities and stable living conditions can affect prevention. The report also recommends vaccination in adult service settings where a high proportion of people have HAV risk factors.

That setting-based guidance creates an opportunity to discuss prevention during addiction care. It does not establish that every addiction program has vaccine supplies, vaccination staff, or an onsite vaccination service. A useful discussion with a medical provider can cover:

  • Whether there are records of prior hepatitis A vaccination or previous infection.
  • Whether drug use or another circumstance falls within a recommended vaccination population.
  • Whether chronic liver disease or another health condition changes the prevention discussion.
  • Where vaccination can be assessed and provided, if appropriate.

The same ACIP report says disclosure of a risk factor is not necessary for hepatitis A vaccination: people who have not completed vaccination may request protection. It also says prevaccination testing should not become a barrier for susceptible people. Missing records are worth discussing, but they should not be treated as a reason to abandon the conversation.

Other liver conditions can make this discussion especially important. ACIP recommends hepatitis A vaccination for people with chronic liver disease, including several viral and nonviral causes. This does not mean chronic liver disease makes someone more likely to acquire HAV; the report distinguishes risk of infection from risk of a severe outcome if infection occurs.

How does adult hepatitis B vaccination guidance differ?

The 2022 adult hepatitis B recommendation uses age as a broad pathway to vaccination rather than requiring every younger adult to disclose a particular risk. For people exploring outpatient substance use treatment, that distinction can reduce confusion about whether a sensitive history is necessary. An individualized care plan can identify the question without deciding a person’s medical eligibility.

Published April 1, 2022, the ACIP adult hepatitis B recommendation recommends vaccination for adults ages 19 through 59. It also recommends vaccination for adults 60 and older with hepatitis B risk factors. Adults 60 and older without known risk factors may also receive vaccination. Prior vaccination and infection history still need appropriate consideration.

For ages 19 through 59, the universal recommendation removes the need to establish a qualifying risk factor before vaccination. The report explains that risk-based approaches can miss people because histories are incomplete, time is limited, or people are reluctant to disclose stigmatized experiences. A routine prevention discussion therefore need not begin with proving a particular exposure.

The recommendation for adults 60 and older includes several risk categories. Current or recent injection drug use is one example; sexual exposure, certain medical conditions, and other circumstances also appear in the guidance. The hepatitis A wording about injection and non-injection drug use should not simply be copied into the hepatitis B risk categories. Each recommendation needs to be read on its own terms.

Vaccination history matters, too. The 2022 report says people who have completed a hepatitis B vaccine series or have a history of HBV infection generally should not receive additional vaccination, while identifying exceptions requiring clinical judgment. The useful next step is a record review with a qualified provider, not an automatic assumption that everyone entering addiction care needs more vaccine.

How do hepatitis B screening and vaccination fit together?

Screening and vaccination complement each other, but neither replaces the other. Adults considering admission to outpatient care can raise both questions without assuming either service is included. The broader purpose of an individualized addiction care plan is to keep relevant needs visible and connect them with the right kind of professional care.

The CDC’s 2023 hepatitis B screening recommendations call for screening at least once during a lifetime for adults 18 and older, using three laboratory tests known as the triple panel. Notice that this adult screening threshold differs from the ages 19 through 59 highlighted in the 2022 universal adult vaccination recommendation. They are separate recommendations serving different purposes.

Three distinct medical-prevention questions

QuestionWhat the cited guidance addressesImportant distinction
Hepatitis A vaccinationThe 2020 ACIP guidance includes people who use injection or non-injection drugs.The recommendation is not limited to injection-related exposure.
Hepatitis B vaccinationThe 2022 ACIP guidance recommends vaccination for adults ages 19 through 59.This age group does not need a qualifying risk-factor disclosure.
Hepatitis B screeningThe 2023 CDC guidance recommends lifetime screening at least once for adults 18 and older.A blood test and a vaccine serve different purposes.

The triple panel includes hepatitis B surface antigen, antibody to hepatitis B surface antigen, and total antibody to hepatitis B core antigen. Together, these results can help clinicians distinguish patterns consistent with current infection, past infection, vaccine-related immunity, or susceptibility. Results require clinical interpretation. A single result taken out of context should not be used to decide independently whether someone needs vaccination or medical follow-up.

CDC says clinicians do not need to wait for screening results before administering an indicated first or next vaccine dose. Its guidance recommends collecting screening blood before vaccination when both occur during a visit. It also states that screening should not be a barrier to hepatitis B vaccination, particularly when access to care is limited. If testing is not feasible or is declined, vaccination should continue according to ACIP recommendations, with testing offered again later.

These provisions do not make screening unimportant. They prevent a useful service from becoming an unnecessary obstacle to another useful service. If screening identifies active infection, the next need is linkage to medical evaluation and care. Vaccination is prevention, not a treatment for an infection already present.

How can a care plan support the next medical step?

A care plan can identify an unresolved prevention question, the professional responsible for answering it, and practical barriers to follow-through. River City Recovery’s outpatient services include care coordination and case management. Its admissions process can explain available support and program fit. Ask specifically how outside medical needs may be coordinated rather than assuming vaccination is part of enrollment.

A useful record does not need to turn vaccination into an addiction-treatment requirement. It can simply distinguish what is known from what still needs medical review. For example, “vaccination history unknown” is different from “not vaccinated,” and “needs a medical appointment” is different from “has hepatitis.” Keeping those distinctions clear avoids turning uncertainty into an unsupported diagnosis.

  • Gather available information. Bring vaccination records, relevant test results, and the names of medical providers already involved. Do not guess when details are unknown.
  • Separate the questions. Ask about hepatitis A prevention, hepatitis B prevention, and hepatitis B screening individually rather than treating “hepatitis care” as one service.
  • Clarify responsibility. Identify which medical provider will assess vaccination needs, explain testing, and handle any results requiring follow-up.
  • Discuss practical barriers. Ask whether care coordination can help address appointment planning, transportation concerns, or communication with another provider, without assuming a particular resource is available.

The vaccination provider also needs information relevant to safety. Both the hepatitis A vaccine information and the hepatitis B vaccine information advise discussing a previous vaccine-related allergic reaction or severe, life-threatening allergies. They also explain that a provider may postpone vaccination in some circumstances. These are reasons for a medical conversation, not for making a vaccine choice independently.

A loved one can help gather records, write down questions, or offer practical support if the adult wants that help. Participation should respect the adult’s choices and privacy. Someone can ask general questions about outpatient care without taking over another person’s medical decisions or assuming access to private health information.

River City Recovery serves adults in Columbus, GA with outpatient addiction and mental health care. Call 706-617-4970 to discuss outpatient options and available coordination. Confirm hepatitis vaccination, screening, and specialty-care arrangements with an appropriate medical provider. Addiction care and preventive medical care can remain connected while each stays within its proper role.

Frequently asked questions

What is the difference between hepatitis A, B, and C vaccination?

Hepatitis A and hepatitis B vaccination address prevention of two different viral infections. Their recommendations and transmission patterns differ, so they should be discussed separately. Hepatitis C testing and treatment are separate medical questions. A conversation about HAV or HBV vaccination does not establish a person’s hepatitis C status or replace appropriate medical evaluation.

Why is hepatitis A vaccination discussed for people who use drugs?

The 2020 ACIP recommendations include people who use injection or non-injection illegal drugs. The recommendation is not limited to shared needles or other injection exposures because hepatitis A commonly spreads through the fecal-oral route. A qualified medical provider can review vaccination history and relevant circumstances without treating a public-health recommendation as an individual diagnosis.

What does hepatitis B vaccination guidance say about adults?

The ACIP recommendation published in 2022 recommends hepatitis B vaccination for adults ages 19 through 59 and adults 60 and older with risk factors. Adults 60 and older without known risk factors may also receive vaccination. Prior vaccination, infection history, and individual medical considerations still belong in a discussion with a qualified provider.

Can an addiction program provide hepatitis vaccination?

Services vary by program, so ask directly rather than assuming vaccination is included. River City Recovery provides adult outpatient addiction and mental health care, with care coordination among its services. That does not confirm onsite hepatitis vaccination, screening, or specialty treatment. Appropriate medical providers should assess prevention needs and explain where the needed services are available.

Must hepatitis B screening results come back before vaccination?

The CDC’s 2023 guidance says clinicians do not need to wait for screening results before an indicated vaccine dose. When screening and vaccination occur together, blood collection is recommended first. Screening should not become a barrier to vaccination. The medical provider should coordinate these steps and explain any results that require follow-up.

Explore related information from River City Recovery

Contact River City Recovery